Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-709-6 | CAS number: 31570-04-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1980-06
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- 1000 bone marrow cells (type not specified). No distinction between immature and mature erythrocytes.
- GLP compliance:
- no
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Tris(2,4-ditert-butylphenyl) phosphite
- EC Number:
- 250-709-6
- EC Name:
- Tris(2,4-ditert-butylphenyl) phosphite
- Cas Number:
- 31570-04-4
- Molecular formula:
- C42H63O3P
- IUPAC Name:
- tris(2,4-ditert-butylphenyl) phosphite
- Details on test material:
- - Substance type: organic- Physical state: solid
Constituent 1
Test animals
- Species:
- hamster, Chinese
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 18 - 26 g (females) and 19 - 27 g (males)
- Diet: ad libitum, standard diet: NAFAG No.924
- Water: ad libitum, tap water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 1
- Humidity (%): 55 ± 5
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: polyethylene glycol 400 (PEG 400)
- Concentration of test material in vehicle: 500, 1000, and 2000 mg/kg in 20 mL/kg PEG 400
- Amount of vehicle (if gavage or dermal): 20 mL/kg - Duration of treatment / exposure:
- 48 h
- Frequency of treatment:
- once daily
- Post exposure period:
- 24 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 6
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide, 128 mg/kg in 20 mL/kg PEG 400
- Route of administration: gavage
- Doses / concentrations: 128 mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow from the shafts of both femurs
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES (in addition to information in specific fields):
Bone marrow was harvested from the shafts of both femurs. In a siliconized pipette filled with approx. 0.5 µL rat serum the bone marrow was drawn up. In order to receive a homogeneous suspension the content of pipette was aspirated gently about three times.
DETAILS OF SLIDE PREPARATION:
Small drops of the above mentioned mixture were transferred on the end of a slide, spread out by pulling it behind a polished cover glass and the preparations were air-dried. At the next day the slides were stained in undiluted May-Grünwald solution for 2 min then in May-Grünwald solution/water 1/1 for 2 min and then in Giemsa's, 40 % for 20 min. After being rinsed in methanol 55 % for 5 - 8 sec and washed off twice in water, they were left immersed in water for approx. 2 min. After rinsing with distilled water and air-drying the slides were cleared in Xylol and mounted in Eukitt.
METHOD OF ANALYSIS:
The slides of three female and three male animals each of the negative control group and the treatment groups were examinedIn the positive control group the slides of four female and two male animals were analysed. 1000 bone marrow cells each were scored per animal and the following anomalies were registered:a) Single Jolly bodies, b) fragments of nuclei in erythrocytes,c) micronuclei in erythroblasts, d) micronuclei in leucopoietic cells, e) polyploid cells. - Statistics:
- The significance of difference was assessed by χ2- test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not examined
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
Any other information on results incl. tables
In the control group one female and one male animal died after the second application. In the positive control group one male animal died after the second application.
In all dosage groups the percentage of cells displaying anomalies of nuclei did not differ significantly from the negative control. By contrast, the positive control (cyclophosphamide, 128 mg/kg) yielded a marked increase of the percentage of cells with anomalies. Here the mean percentage of anomalies was 7.9, whereas the negative control yielded a percentage of 0.1. The difference was highly significant (p<0.05).
percent of cells with anomalies of nuclei | ||||||||
number of animal | sex of animal | single jolly bodies | frasgments of nuclei in erythrocytes | micronuclei in erythroblasts | micronuclei in leucopoietic cells | polyploid cells | total | |
Control (PEG 400) |
1 | f | 0.1 | 0.1 | ||||
2 | f | 0.1 | 0.1 | |||||
3 | f | 0.1 | 0.1 | 0.2 | ||||
4 | m | 0 | ||||||
5 | m | 0.1 | 0.1 | |||||
6 | m | 0.1 | 0.1 | |||||
Cyclophosphamide (128 mg/kg) |
1 | f | 5.2 | 0.2 | 0.6 | 0.2 | 0.3 | 6.5 |
2 | f | 4.4 | 0.9 | 0.7 | 0.3 | 6.3 | ||
3 | f | 3 | 1.2 | 0.7 | 4.9 | |||
4 | m | 4.1 | 1.9 | 0.1 | 0.1 | 6.2 | ||
5 | m | 10.6 | 1.5 | 1.5 | 0.8 | 0.3 | 14.7 | |
6 | m | 6.8 | 0.7 | 1.1 | 0.1 | 0.1 | 8.8 | |
test article (500 mg/kg) | 1 | f | 0.2 | 0.2 | ||||
2 | f | 0.3 | 0.3 | |||||
3 | f | 0 | ||||||
4 | m | 0.1 | 0.1 | |||||
5 | m | 0 | ||||||
6 | m | 0.2 | 0.2 | |||||
test article (1000 mg/kg) | 1 | f | 0.2 | 0.1 | 0.3 | |||
2 | f | 0.1 | 0.1 | |||||
3 | f | 0.2 | 0.2 | |||||
4 | m | 0.1 | 0.1 | |||||
5 | m | 0.1 | 0.1 | |||||
6 | m | 0.1 | 0.1 | |||||
test article (2000 mg/kg) | 1 | f | 0.1 | 0.1 | ||||
2 | f | 0 | ||||||
3 | f | 0.3 | 0.3 | |||||
4 | m | 0.1 | 0.1 | |||||
5 | m | 0.1 | 0.1 | |||||
6 | m | 0.1 | 1 |
Applicant's summary and conclusion
- Conclusions:
- The MNT assay in chinese hamster was found to be negative.
Under the conditions of this experiment, no evidence of mutagenic effects was obtained with the test article.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.